Kyntra Bio (KYNB) Finished Goods (2018 - 2024)

Kyntra Bio has disclosed Finished Goods across 7 years of filings, most recently posting $5.2 million for Q3 2024.

• In Q3 2024, Finished Goods rose 13.08% year-over-year to $5.2 million; the TTM figure through Sep 2024 stood at $5.2 million (up 13.08% YoY), while the FY2023 annual figure was $5.6 million, up 74.66% from the prior year.
• Finished Goods came in at $5.2 million for Q3 2024 at Kyntra Bio, up from $4.9 million in the prior quarter.
• In the past five years, Finished Goods ranged from a high of $8.2 million in Q4 2021 to a low of $3.2 million in Q4 2022.
• Average Finished Goods over 5 years is $5.6 million, with a median of $5.2 million recorded in 2022.
• Year-over-year, Finished Goods jumped 2879.87% in 2020 and sank 60.85% in 2022.
• Over 5 years, Finished Goods stood at $6.1 million in 2020, then soared by 33.37% to $8.2 million in 2021, then sank by 60.85% to $3.2 million in 2022, then jumped by 74.66% to $5.6 million in 2023, then dropped by 6.48% to $5.2 million in 2024.
• Per Business Quant data, the three most recent Finished Goods figures were $5.2 million in Q3 2024, $4.9 million in Q2 2024, and $5.7 million in Q1 2024.